Asthenia
Information
- Disease name
- Asthenia
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04546607 | Completed | Phase 2/Phase 3 | Evaluation of Clinical Efficacy and Safety of Nuvastatic in Cancer Asthenia | September 2, 2017 | October 31, 2019 |
| NCT05689827 | Completed | Phase 4 | Safety and Efficacy of the Therapy With BRAINMAX® for the Treatment of Patients With Asthenia After COVID-19 | April 5, 2022 | November 10, 2022 |
| NCT05939622 | Completed | Phase 4 | Efficacy of the Therapy With BRAINMAX® Using fMRI for the Treatment of Patients With Asthenia After COVID-19 | May 18, 2022 | December 20, 2022 |
| NCT00273741 | Terminated | Phase 3 | Ritalin: Antiasthenic Effect of Methylphenidate (Ritalin) in Palliative Care in Cancer Patients | January 2007 | June 2009 |
| NCT01773837 | Terminated | Phase 3 | Clinical Trial to Evaluate Short-term Efficacy of Palliative Methylphenidate in Asthenia in Advanced Cancer Patients | January 2012 | February 2018 |
| NCT02298374 | Withdrawn | N/A | Evaluation of Homecare Reablement, the Trondheim Model | November 2014 | June 2017 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0025406
- MeSH unique ID (MeSH (Medical Subject Headings))
- D001247